Cargando…
Mesenchymal stem cells decrease lung inflammation during sepsis, acting through inhibition of the MAPK pathway
BACKGROUND: Sepsis is a severe medical condition that ranks among the top 10 causes of death worldwide and which has permanently high incidence rates. Mesenchymal stem cells (MSCs) have been found to be potent modulators of immune responses. More importantly, there is evidence that MSCs have a benef...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741936/ https://www.ncbi.nlm.nih.gov/pubmed/29273091 http://dx.doi.org/10.1186/s13287-017-0734-8 |